NBTX Nanobiotix S.A. - ADSs
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 31, 2026
$25.75
· of 52w range
· above low
· to high
$14.7852w low
$57.1452w high
P/E
-46.2
EPS
$-0.50
Revenue
$33M
your badges
52W Range
$15–$57
Analyst Rating
BUY
Price Target
$54
P/E
-46.2
ROE
31.9%
Net Profit Margin
-73.5%
Your badge strip is empty — pin a metric anywhere on this page.
NBTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$25.75
P/E
-46.2
EPS
$-0.50
Revenue
$33M
ROE
31.9%
52W Range
$15–$57
NBTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$33M2018-12-31 → 2025-12-31
EPS$-0.502018-12-31 → 2025-12-31
Free Cash Flow$-34M2020-12-31 → 2025-12-31
Net margin-73.5%2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NBTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -46.25Y avg ≈-12.6 | ≈-12.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NBTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -33.2%5Y avg ≈-424.1% | ≈-424.1% | · | · | |
| EBITDA Margin | -33.2%5Y avg ≈-424.1% | ≈-424.1% | · | · | |
| Pretax Margin | -73.5%5Y avg ≈-441.2% | ≈-441.2% | · | · | |
| Net Profit Margin | -73.5%5Y avg ≈-441.6% | ≈-441.6% | · | · | |
| ROA | -35.4%5Y avg ≈-56.4% | ≈-56.4% | · | · | |
| ROE | 31.9%5Y avg ≈9029.9% | ≈9029.9% | · | · | |
| ROIC | 12.8%5Y avg ≈310.2% | ≈310.2% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NBTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 1.15Y avg ≈1.6 | ≈1.6 | · | · | |
| Quick Ratio | 0.05Y avg ≈1.0 | ≈1.0 | · | · | |
| Interest Coverage | -0.75Y avg ≈-16.5 | ≈-16.5 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NBTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.2 | ≈0.2 | · | · | |
| Revenue / Employee | ≈$325.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-196.0%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.70 | $-0.12 | -496.8% | |
| Dec. 31, 2025 | $-0.39 | $0.56 | -170.2% | |
| June 30, 2025 | $-0.11 | $-0.32 | 65.2% | |
| Dec. 31, 2024 | $-0.98 | $-0.55 | -79.6% | |
| June 30, 2024 | $-0.46 | $-0.21 | -120.0% | |
| Dec. 31, 2023 | $-0.28 | $0.10 | -374.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $-7M | $36M | $5M | $3M | $3M | $3M | $3M | |
| R&D Expense | $23M | $41M | $38M | $33M | $30M | $24M | $30M | $21M | |
| SG&A Expense | $20M | $21M | $22M | $18M | $19M | $15M | $19M | $13M | |
| Operating Income | $-11M | $-68M | $-27M | $-47M | $-53M | $-36M | $-47M | $-30M | |
| Interest Expense | $15M | $7M | $15M | $14M | $780.0K | $-3M | $5M | $847.0K | |
| Interest Income | $2M | $8M | $2M | $4M | $6M | $201.0K | $837.0K | $1M | |
| Pretax Income | $-24M | $-68M | $-40M | $-57M | $-47M | $-34M | $-51M | $-30M | |
| Income Tax | $3.0K | $101.0K | $120.0K | $10.0K | $5.0K | $9.0K | $3.0K | $0 | |
| Net Income | $-24M | $-68M | $-40M | $-57M | $-47M | $-34M | $-51M | $-30M | |
| EPS (Basic) | $-0.50 | $-1.44 | $-1.08 | $-1.64 | $-1.35 | $-1.38 | $-2.35 | $-1.55 | |
| EPS (Diluted) | $-0.50 | $-1.44 | $-1.08 | $-1.64 | $-1.35 | $-1.38 | $-2.35 | $-1.55 | |
| Shares (Basic) | 47,819,627,000 | 47,265,189,000 | 36,928,161,000 | 34,851,868,000 | 34,733,418,000 | 24,385,827,000 | 21,631,514,000 | 19,633,373,000 | |
| EBITDA | $-11M | $-68M | $-27M | $-47M | $-53M | $-36M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $810.0K | $5M | $75M | $39M | $84M | $119M | $25M | · | |
| Current Assets | $63M | $61M | $87M | $52M | $93M | $125M | $46M | · | |
| PP&E (Net) | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $8M | |
| Intangibles | $10.0K | $7.0K | $8.0K | $1.0K | $4.0K | $21.0K | $163.0K | $102.0K | |
| Total Assets | $68M | $67M | $94M | $60M | $102M | $134M | $56M | · | |
| Accounts Payable | $9M | $20M | $18M | $10M | $6M | $7M | $8M | · | |
| Current Liabilities | $58M | $59M | $50M | $38M | $37M | $19M | $14M | · | |
| Total Liabilities | $152M | $133M | $96M | · | · | · | · | · | |
| Retained Earnings | $-401M | $-380M | $-316M | $-227M | · | · | · | · | |
| Stockholders' Equity | $-84M | $-66M | $-2M | $-27M | $27M | $70M | $-2M | $14M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-33M | $-20M | $-12M | $-37M | $-30M | $-28M | $-41M | $-26M | |
| CapEx | $538.0K | $846.0K | $328.0K | $92.0K | $228.0K | $96.0K | $1M | $416.0K | |
| Investing Cash Flow | $-578.0K | $-955.0K | $-349.0K | $138.0K | $-242.0K | $-112.0K | $-1M | $71.0K | |
| Financing Cash Flow | $37M | $-5M | $47M | $-6M | $-5M | $112M | $41M | $15M | |
| Free Cash Flow | $-34M | $-20M | $-13M | $-37M | $-30M | $-28M | · | · | |
| Levered FCF | $-49M | $-28M | $-28M | $-51M | $-31M | $-23M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -33.2% | 951.1% | -74.0% | -977.8% | -1986.4% | -1450.2% | · | · | |
| Net Margin | -73.5% | 947.5% | -109.7% | -1194.3% | -1778.0% | -1337.2% | · | · | |
| Pretax Margin | -73.5% | 947.5% | -109.7% | -1194.3% | -1775.7% | -1337.2% | · | · | |
| EBITDA Margin | -33.2% | 951.1% | -74.0% | -977.8% | -1986.4% | -1450.2% | · | · | |
| ROA | -35.4% | -84.5% | -51.7% | -70.6% | -39.9% | -35.3% | · | · | |
| ROE | 31.9% | 201.7% | 274.9% | 44738.0% | -96.8% | -98.0% | · | · | |
| ROIC | 12.8% | 104.2% | 1457.4% | 172.7% | -196.3% | -51.7% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.0 | 1.8 | 1.4 | 2.5 | 6.6 | · | · | |
| Quick Ratio | 0.0 | 0.1 | 1.5 | 1.0 | 2.3 | 6.3 | · | · | |
| Interest Coverage | -0.7 | -9.1 | -1.8 | -3.4 | -67.4 | 7.8 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | -0.1 | 0.5 | 0.1 | 0.0 | 0.0 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-0.50 | $-1.44 | $-1.08 | $-1.64 | $-1.35 | $-1.38 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $33M | $-7M | $36M | $5M | $3M | $3M | · | · | |
| Net Income TTM | $-24M | $-68M | $-40M | $-57M | $-47M | $-34M | · | · | |
| P/E | -46.2 | -2.0 | -6.7 | -2.2 | -6.0 | -12.0 | · | · | |
| Earnings Yield | -2.2% | -50.2% | -14.8% | -44.7% | -16.7% | -8.4% | · | · |
No quarterly filings for NBTX
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $33M | $-7M | $36M | $5M | $3M |
| Operating Margin % | -33.2% | 951.1% | -74.0% | -977.8% | -1986.4% |
| Net Income | $-24M | $-68M | $-40M | $-57M | $-47M |
| Diluted EPS | $-0.50 | $-1.44 | $-1.08 | $-1.64 | $-1.35 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.0 | 1.8 | 1.4 | 2.5 |
| Quick Ratio | 0.0 | 0.1 | 1.5 | 1.0 | 2.3 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-34M | $-20M | $-13M | $-37M | $-30M |
Institutional owners (13F) 19 filers · $217.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
19
Value held
$217.3M
New positions
7
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+5 vs prior Q) | 3 (+2 vs prior Q) | 6 (+3 vs prior Q) | 2 (-3 vs prior Q) | +94K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JOHNSON & JOHNSON | $212,017,863 | 5,623,816 | 97.55% | Shares |
| MORGAN STANLEY | $1,877,045 | 49,789 | 0.86% | Shares |
| JANE STREET GROUP, LLC | $1,213,186 | 32,180 | 0.56% | Shares |
| XTX Topco Ltd | $597,734 | 15,855 | 0.28% | Shares |
| Optiver Holding B.V. | $513,889 | 13,631 | 0.24% | Shares |
| MARSHALL WACE, LLP | $378,659 | 10,044 | 0.17% | Shares |
| CITADEL ADVISORS LLC | $227,783 | 6,042 | 0.10% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $152,459 | 4,044 | 0.07% | Shares |
| UBS Group AG | $97,153 | 2,577 | 0.04% | Shares |
| ROYAL BANK OF CANADA | $83,000 | 2,189 | 0.04% | Shares |
| JPMORGAN CHASE & CO | $61,348 | 1,706 | 0.03% | Shares |
| RHUMBLINE ADVISERS | $56,622 | 1,502 | 0.03% | Shares |
| GAMMA Investing LLC | $37,135 | 985 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $18,850 | 500 | 0.01% | Shares |
| WELLS FARGO & COMPANY/MN | $7,540 | 200 | 0.00% | Shares |
| Stone House Investment Management, LLC | $2,865 | 76 | 0.00% | Shares |
| Federation des caisses Desjardins du Quebec | $2,111 | 56 | 0.00% | Shares |
| HRT FINANCIAL LP | $1,030 | 27,332 | 0.00% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $482 | 13 | 0.00% | Shares |
NBTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$63.37
+146.1%
4 33.3%
Strong Buy
6 50.0%
Buy
2 16.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $54.11 +110.1%
← Below all targets
Current price $25.75
Low$29.64
Mean$54.11
High$69.31
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 31, 2026